tradingkey.logo

Actuate Therapeutics Inc

ACTU

6.640USD

-0.225-3.28%
Close 09/19, 16:00ETQuotes delayed by 15 min
135.92MMarket Cap
LossP/E TTM
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q1
Operating expenses
9.81%5.97M
-18.11%6.37M
--6.56M
--5.39M
--5.44M
46.71%7.77M
--5.30M
R&D expenses
-36.77%2.76M
-53.06%3.22M
--3.69M
--3.76M
--4.37M
51.65%6.86M
--4.52M
Operating profit
-9.81%-5.97M
18.11%-6.37M
---6.56M
---5.39M
---5.44M
-46.71%-7.77M
---5.30M
Net non-operating interest income (expenses)
Non-operating interest income
183.79%24.53K
262.66%53.62K
--118.11K
--80.75K
--8.64K
-71.37%14.79K
--51.65K
Non-operating interest expense
-0.28%5.06K
-0.26%5.06K
--5.08K
--3.49K
--5.08K
-82.16%5.08K
--28.45K
Special income (expenses)
100.00%0.00
100.00%0.00
--0.00
---655.32K
---1.14M
-10533.29%-532.51K
--5.10K
Income before tax
9.48%-5.95M
23.86%-6.32M
---6.45M
---5.97M
---6.57M
-57.41%-8.30M
---5.27M
Income after tax
9.48%-5.95M
23.86%-6.32M
---6.45M
---5.97M
---6.57M
-57.41%-8.30M
---5.27M
Net income from continuous operations
9.48%-5.95M
23.86%-6.32M
---6.45M
---5.97M
---6.57M
-57.41%-8.30M
---5.27M
Net income attributable to controlling interests
9.48%-5.95M
23.86%-6.32M
---6.45M
---5.97M
---6.57M
-57.41%-8.30M
---5.27M
Net income attributable to common shareholders
9.48%-5.95M
23.86%-6.32M
---6.45M
---5.97M
---6.57M
-57.41%-8.30M
---5.27M
Basic earnings per share
11.94%-0.30
25.36%-0.32
---0.31
---0.31
---0.34
-57.41%-0.43
---0.28
Diluted earnings per share
11.94%-0.30
25.36%-0.32
---0.31
---0.31
---0.34
-57.41%-0.43
---0.28
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
KeyAI